Trial intelligence / Profile preview

Olanzapine standard tablets versus orally disintegrating tablets on metabolic and hormonal outcomes in healthy volunteers

NL-OMON29380Active, not recruiting

Sponsor
Leiden University Medical Center
Start
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of olanzapine (3 arms), sponsored by Leiden University Medical Center. Primary endpoints: Anthropometric measurements, Indirect calorimetry outcomes and 3 more. Started Apr 2006; status: active, not recruiting.

02

Drugs

olanzapine

Beyond the preview

Go deeper on NL-OMON29380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON29380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call